Tilray Brands (TLRY) Net Cash Flow (2017 - 2026)
Tilray Brands (TLRY) reported Net Cash Flow of $1.8 million for Q1 2026, down 84.85% on a YoY basis from $12.2 million in Q1 2025, and up 110.02% quarter-over-quarter from -$18.4 million in Q4 2025.
Tilray Brands (TLRY) Net Cash Flow (2017 - 2026) Analysis & Trends
Tilray Brands has reported Net Cash Flow for 10 years, with the latest figure at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 84.85% year-over-year to $1.8 million; the trailing twelve-month figure through Feb 2026 stood at $43.7 million (down 24.16% YoY), and the FY2025 full-year result was -$7.8 million, down 135.09% from the prior year.
- Net Cash Flow for Q1 2026 stood at $1.8 million, up from -$18.4 million in the prior quarter.
- The five-year high for Net Cash Flow was $136.4 million in Q2 2022, with the low at -$299.4 million in Q4 2022.
- Historically, Net Cash Flow has averaged -$4.9 million across 5 years, with a median of $1.8 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 578.83% — and 2025, when it surged 571.31%.
- Tilray Brands' Net Cash Flow stood at -$299.4 million in 2022, then surged by 88.55% to -$34.3 million in 2023, then jumped by 61.36% to -$13.2 million in 2024, then slumped by 39.23% to -$18.4 million in 2025, then soared by 110.02% to $1.8 million in 2026.
- The last three Net Cash Flow figures came in at $1.8 million (Q1 2026), -$18.4 million (Q4 2025), and $43.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -3.97 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 139.49 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.85 Mn |
| Feb 28, 2026 | 1.85 Mn |
| Nov 30, 2025 | -18.44 Mn |
| Nov 30, 2025 | -18.44 Mn |
| Aug 31, 2025 | 42.97 Mn |
| Aug 31, 2025 | 42.97 Mn |
| May 31, 2025 | 17.36 Mn |
| May 31, 2025 | 17.36 Mn |
| Feb 28, 2025 | 12.19 Mn |
| Feb 28, 2025 | 12.19 Mn |
| Nov 30, 2024 | -13.25 Mn |
| Nov 30, 2024 | -13.25 Mn |
| Aug 31, 2024 | -24.11 Mn |
| Aug 31, 2024 | -24.11 Mn |
| May 31, 2024 | 82.83 Mn |
| May 31, 2024 | 82.83 Mn |
| Feb 29, 2024 | 1.82 Mn |
| Feb 29, 2024 | 1.82 Mn |
| Nov 30, 2023 | -34.28 Mn |
| Nov 30, 2023 | -34.28 Mn |